Teicoplanin: Difference between revisions
Jump to navigation
Jump to search
imported>Meg Taylor m (grammar: gram -> Gram) |
mNo edit summary |
||
| Line 8: | Line 8: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 11:00, 25 October 2024
In medicine and pharmacology, teicoplanin is a "glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against Gram-positive bacteria. It consists of five major components each with a different fatty acid moiety."[1][2]
Other glycopeptide antibiotics include vancomycin and dalbavancin.
Teicoplanin can be used to treat pseudomembranous enterocolitis due to Clostridium difficile.[3]
References
- ↑ Anonymous (2024), Teicoplanin (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Finch RG, Eliopoulos GM (March 2005). "Safety and efficacy of glycopeptide antibiotics". J. Antimicrob. Chemother. 55 Suppl 2: ii5–13. DOI:10.1093/jac/dki004. PMID 15750036. Research Blogging.
- ↑ Smith GC (April 1995). "What can consultation-liaison psychiatry contribute to psychosomatic research?". J Psychosom Res 39 (3): 247–50. PMID 7636768. [e]